1,2-dichloroethane increases expression ISO RGD:1550820 6480464 ethylene dichloride results in increased expression of SMARCA4 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1550820 6480464 1, 2-Dimethylhydrazine results in increased expression of SMARCA4 mRNA CTD PMID:22206623 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine decreases expression EXP 6480464 chlorcyclizine results in decreased expression of SMARCA4 mRNA CTD PMID:21058326 17alpha-ethynylestradiol multiple interactions ISO RGD:1550820 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1550820 6480464 Ethinyl Estradiol results in increased expression of SMARCA4 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1348890 6480464 Estradiol results in decreased expression of SMARCA4 mRNA CTD PMID:16705744 , PMID:19167446 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:1348890 6480464 [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein] CTD PMID:18487222 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1348890 6480464 SMARCA4 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] more ... CTD PMID:18842620 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SMARCA4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550820 6480464 Tetrachlorodibenzodioxin affects the expression of SMARCA4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SMARCA4 mRNA CTD PMID:18796159 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550820 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA4 mRNA CTD PMID:17942748 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550820 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SMARCA4 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SMARCA4 protein CTD PMID:34915118 acetamide increases expression EXP 6480464 acetamide results in increased expression of SMARCA4 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1348890 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SMARCA4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SMARCA4 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:1550820 6480464 Aflatoxin B1 results in increased expression of SMARCA4 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1348890 6480464 Aflatoxin B1 results in increased methylation of SMARCA4 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:1550820 6480464 [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] more ... CTD PMID:29457851 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of SMARCA4 mRNA CTD PMID:24977338 all-trans-retinoic acid decreases expression ISO RGD:1348890 6480464 Tretinoin results in decreased expression of SMARCA4 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1348890 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SMARCA4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SMARCA4 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SMARCA4 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SMARCA4 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1348890 6480464 Antirheumatic Agents results in decreased expression of SMARCA4 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1550820 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SMARCA4 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1348890 6480464 Arsenic affects the methylation of SMARCA4 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1348890 6480464 Arsenic affects the methylation of SMARCA4 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1348890 6480464 Arsenic Trioxide results in increased expression of SMARCA4 mRNA CTD PMID:20458559 atrazine decreases expression ISO RGD:1348890 6480464 Atrazine results in decreased expression of SMARCA4 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1550820 6480464 Benzo(a)pyrene results in increased expression of SMARCA4 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1348890 6480464 Benzo(a)pyrene affects the methylation of SMARCA4 intron CTD PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:1348890 6480464 benzo(e)pyrene results in increased methylation of SMARCA4 intron CTD PMID:30157460 Benzo[ghi]perylene increases expression ISO RGD:1348890 6480464 1, 12-benzoperylene results in increased expression of SMARCA4 mRNA CTD PMID:35182551 bicalutamide multiple interactions ISO RGD:1348890 6480464 [Dihydrotestosterone co-treated with bicalutamide] promotes the reaction [AR protein binds to SMARCA4 protein] more ... CTD PMID:18487222 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SMARCA4 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SMARCA4 mRNA CTD PMID:30816183 , PMID:33296240 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SMARCA4 mRNA CTD PMID:19167457 caffeine affects phosphorylation ISO RGD:1348890 6480464 Caffeine affects the phosphorylation of SMARCA4 protein CTD PMID:35688186 carbon nanotube increases expression ISO RGD:1550820 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of SMARCA4 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1550820 6480464 SMARCA4 gene mutant form results in decreased susceptibility to [Methionine deficiency co-treated with Choline deficiency] CTD PMID:29963902 cisplatin multiple interactions ISO RGD:1348890 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SMARCA4 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1348890 6480464 Cisplatin results in decreased expression of SMARCA4 mRNA CTD PMID:27392435 , PMID:27594783 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of SMARCA4 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:1348890 6480464 cobaltous chloride results in decreased expression of SMARCA4 mRNA CTD PMID:19320972 cobalt dichloride multiple interactions ISO RGD:1348890 6480464 cobaltous chloride promotes the reaction [[SMARCA4 protein binds to SMARCA2 protein] which binds to COL7A1 gene] more ... CTD PMID:30381462 cocaine multiple interactions EXP 6480464 [Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to SMARCA4 promoter] more ... CTD PMID:27422367 , PMID:30158054 cocaine increases expression EXP 6480464 Cocaine deficiency results in increased expression of SMARCA4 protein CTD PMID:27422367 copper atom multiple interactions ISO RGD:1348890 6480464 [Chelating Agents binds to Copper] which results in decreased expression of SMARCA4 mRNA CTD PMID:31162603 copper(0) multiple interactions ISO RGD:1348890 6480464 [Chelating Agents binds to Copper] which results in decreased expression of SMARCA4 mRNA CTD PMID:31162603 coumarin affects phosphorylation ISO RGD:1348890 6480464 coumarin affects the phosphorylation of SMARCA4 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:1348890 6480464 Asbestos, Crocidolite results in decreased expression of SMARCA4 mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:1348890 6480464 Cyclosporine results in decreased expression of SMARCA4 mRNA CTD PMID:22147139 cyclosporin A increases expression ISO RGD:1348890 6480464 Cyclosporine results in increased expression of SMARCA4 mRNA CTD PMID:25562108 cyproconazole decreases expression ISO RGD:1550820 6480464 cyproconazole results in decreased expression of SMARCA4 mRNA CTD PMID:22334560 D-glucose multiple interactions ISO RGD:1550820 6480464 [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] more ... CTD PMID:29457851 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of SMARCA4 mRNA CTD PMID:23640034 diarsenic trioxide increases expression ISO RGD:1348890 6480464 Arsenic Trioxide results in increased expression of SMARCA4 mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:1550820 6480464 Dibutyl Phthalate results in decreased expression of SMARCA4 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos increases expression ISO RGD:1348890 6480464 dicrotophos results in increased expression of SMARCA4 mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:1550820 6480464 [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] more ... CTD PMID:29457851 dioxygen multiple interactions ISO RGD:1348890 6480464 SMARCA4 protein promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA], SMARCA4 protein promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA] CTD PMID:30381462 dorsomorphin multiple interactions ISO RGD:1348890 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA4 mRNA CTD PMID:27188386 elemental selenium increases expression ISO RGD:1348890 6480464 Selenium results in increased expression of SMARCA4 mRNA CTD PMID:19244175 epoxiconazole decreases expression ISO RGD:1550820 6480464 epoxiconazole results in decreased expression of SMARCA4 mRNA CTD PMID:22334560 ethanol multiple interactions ISO RGD:1550820 6480464 Ethanol affects the expression of and affects the splicing of SMARCA4 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1348890 6480464 Ethyl Methanesulfonate results in decreased expression of SMARCA4 mRNA CTD PMID:23649840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SMARCA4 mRNA CTD PMID:30307764 finasteride increases expression EXP 6480464 Finasteride results in increased expression of SMARCA4 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SMARCA4 mRNA CTD PMID:20566332 , PMID:24136188 fulvestrant decreases expression ISO RGD:1348890 6480464 fulvestrant results in decreased expression of SMARCA4 protein CTD PMID:24169358 gallic acid decreases expression ISO RGD:1348890 6480464 Gallic Acid results in decreased expression of SMARCA4 mRNA CTD PMID:34408198 genistein increases expression ISO RGD:1348890 6480464 Genistein results in increased expression of SMARCA4 mRNA CTD PMID:16705744 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SMARCA4 mRNA CTD PMID:22061828 glucose multiple interactions ISO RGD:1550820 6480464 [MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] more ... CTD PMID:29457851 graphene oxide increases expression ISO RGD:1348890 6480464 graphene oxide results in increased expression of SMARCA4 mRNA CTD PMID:33219560 , PMID:33219585 hexadecanoic acid increases phosphorylation ISO RGD:1348890 6480464 Palmitic Acid results in increased phosphorylation of SMARCA4 protein CTD PMID:28073184 hydrazine increases expression ISO RGD:1550820 6480464 hydrazine results in increased expression of SMARCA4 mRNA CTD PMID:15282401 ivermectin decreases expression ISO RGD:1348890 6480464 Ivermectin results in decreased expression of SMARCA4 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1550820 6480464 SMARCA4 gene mutant form results in decreased susceptibility to [Methionine deficiency co-treated with Choline deficiency] CTD PMID:29963902 methapyrilene increases methylation ISO RGD:1348890 6480464 Methapyrilene results in increased methylation of SMARCA4 intron CTD PMID:30157460 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SMARCA4 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO RGD:1348890 6480464 Methyl Methanesulfonate results in decreased expression of SMARCA4 mRNA CTD PMID:23649840 methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of SMARCA4 mRNA CTD PMID:20864626 methylmercury chloride multiple interactions ISO RGD:1348890 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA4 mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1348890 6480464 methylmercuric chloride results in increased expression of SMARCA4 mRNA CTD PMID:23179753 , PMID:26272509 methylseleninic acid decreases expression ISO RGD:1348890 6480464 methylselenic acid results in decreased expression of SMARCA4 mRNA CTD PMID:18548127 motexafin gadolinium decreases expression ISO RGD:1348890 6480464 motexafin gadolinium results in decreased expression of SMARCA4 mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions ISO RGD:1348890 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA4 mRNA CTD PMID:16357179 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SMARCA4 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1348890 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SMARCA4 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:1348890 6480464 Acetaminophen results in decreased expression of SMARCA4 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SMARCA4 mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:1550820 6480464 [SIRT6 protein mutant form results in decreased activity of SIRT6 protein] inhibits the reaction [Paraquat promotes the reaction [SMARCA4 protein binds to HMOX1 enhancer]] more ... CTD PMID:31216030 perfluorooctanoic acid decreases expression ISO RGD:1550820 6480464 perfluorooctanoic acid results in decreased expression of SMARCA4 protein CTD PMID:36214631 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SMARCA4 mRNA CTD PMID:12082028 phenobarbital decreases expression ISO RGD:1550820 6480464 Phenobarbital results in decreased expression of SMARCA4 mRNA CTD PMID:23091169 poly(propylene imine) macromolecule decreases expression ISO RGD:1348890 6480464 poly(propyleneimine) analog results in decreased expression of SMARCA4 mRNA CTD PMID:16308212 promegestone multiple interactions ISO RGD:1348890 6480464 SMARCA4 protein affects the reaction [Promegestone results in increased expression of FOS mRNA], SMARCA4 protein affects the reaction [Promegestone results in increased expression of MYC mRNA] CTD PMID:19609353 propiconazole decreases expression ISO RGD:1550820 6480464 propiconazole results in decreased expression of SMARCA4 mRNA CTD PMID:22334560 quercetin increases phosphorylation ISO RGD:1348890 6480464 Quercetin results in increased phosphorylation of SMARCA4 protein CTD PMID:35688186 resveratrol decreases expression ISO RGD:1550820 6480464 resveratrol results in decreased expression of SMARCA4 protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1348890 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA4 mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:1348890 6480464 Selenium results in increased expression of SMARCA4 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1348890 6480464 Silicon Dioxide analog results in increased expression of SMARCA4 mRNA CTD PMID:25895662 sodium arsenite multiple interactions ISO RGD:1348890 6480464 SMARCA4 protein affects the reaction [sodium arsenite results in increased expression of HSF1 mRNA] CTD PMID:30309986 sodium arsenite increases expression ISO RGD:1348890 6480464 sodium arsenite results in increased expression of SMARCA4 mRNA CTD PMID:34032870 temozolomide increases expression ISO RGD:1348890 6480464 Temozolomide results in increased expression of SMARCA4 mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:1550820 6480464 Carbon Tetrachloride results in increased expression of SMARCA4 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:1550820 6480464 Thapsigargin results in increased expression of SMARCA4 protein CTD PMID:24648495 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of SMARCA4 protein CTD PMID:35544339 titanium dioxide increases expression ISO RGD:1550820 6480464 titanium dioxide results in increased expression of SMARCA4 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SMARCA4 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1348890 6480464 SMARCA4 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SMARCA4 mRNA CTD PMID:33387578 tungsten decreases expression ISO RGD:1550820 6480464 Tungsten results in decreased expression of SMARCA4 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1348890 6480464 Tunicamycin results in decreased expression of SMARCA4 mRNA CTD PMID:22378314 valproic acid increases methylation ISO RGD:1348890 6480464 Valproic Acid results in increased methylation of SMARCA4 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1348890 6480464 Valproic Acid results in decreased expression of SMARCA4 mRNA CTD PMID:28001369 , PMID:29154799 valproic acid affects expression ISO RGD:1348890 6480464 Valproic Acid affects the expression of SMARCA4 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SMARCA4 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SMARCA4 mRNA CTD PMID:18042343 , PMID:23034163 vorinostat decreases expression ISO RGD:1348890 6480464 vorinostat results in decreased expression of SMARCA4 mRNA CTD PMID:27188386 zinc acetate multiple interactions ISO RGD:1348890 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA4 mRNA CTD PMID:16357179 zinc acetate decreases expression ISO RGD:1348890 6480464 Zinc Acetate results in decreased expression of SMARCA4 mRNA CTD PMID:16357179 zinc atom multiple interactions ISO RGD:1348890 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SMARCA4 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1348890 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SMARCA4 mRNA CTD PMID:18593933
